Shot in the Dark

Brown, Heidi
May 2008
Forbes Asia;5/19/2008, Vol. 4 Issue 9, p70
The article presents information about Harriet Robinson, a 70-year-old microbiologist, in Atlanta, Georgia. Robinson and her firm GeoVax Inc. hope to begin a 500-person trial in the 2008 summer with a vaccine for HIV. The vaccine has already demonstrated its safety in humans. In November 2007 the company won a third five-year $15 million grant from the U.S. National Institutes of Health. In the 1960s she was one of the rare women among those receiving Ph.D.s in microbiology.


Related Articles

  • Planning for Posttrial Access to Antiretroviral Treatment for Research Participants in Developing Countries. Shah, Seema; Elmer, Stacey; Grady, Christine // American Journal of Public Health;Sep2009, Vol. 99 Issue 9, p1556 

    Despite recognition of the importance of posttrial access to antiretroviral therapy (ART), the implementation process has not been studied. We examined whether the National Institutes of Health (NIH) guidance document was being implemented in NIH-funded ART trials conducted in developing...

  • Length and complexity of US and international HIV consent forms from federal HIV network trials. Kass, Nancy; Chaisson, Lelia; Taylor, Holly; Lohse, Jennifer; Kass, Nancy E; Taylor, Holly A // JGIM: Journal of General Internal Medicine;Nov2011, Vol. 26 Issue 11, p1324 

    Background: Informed consent is required in most clinical research with humans. While federal regulations state consent information should be understandable to participants, concerns have been raised that consent forms are overly long and complex.Design: Consent forms...

  • Selecting subjects for participation in clinical research: one sphere of justice. Weijer, Charles // Journal of Medical Ethics;Feb99, Vol. 25 Issue 1, p31 

    Provides information on clinical research guidelines mandated by the United States National Institutes of Health (NIH). Eligibility criteria in clinical results; Exclusion of women as domination; Distributive logic of medical research.

  • Army HIV vaccine to undergo clinical trial a rival is halted. Check, Erika // Nature;3/7/2002, Vol. 416 Issue 6876, p6 

    Reports on the decision of National Institute of Health (NIH) to conduct clinical trials for HIV vaccine. Provision of NIH of funding for the trials; Use of different methods to measure immune response level of immune response protected vaccines from the virus.

  • NIH Opens Research Hospital to Outside Scientists.  // Bioscience Technology;2014, p1 

    The article presents information on the opening of research hospitals by the National Institutes of Health (NIH) for outside scientists in the Bethesda, Meryland. Recently the organization announced ten projects inviting non-government researchers to conduct clinical research at the Clinical...

  • NIH project aims to improve, preserve insulin production.  // Endocrine Today;Jun2013, Vol. 11 Issue 6, p19 

    The article reports on the need for Restoring Insulin Secretion (RISE) clinical trial volunteers of the U.S. National Institutes of Health (NIH).

  • National Institutes of Health require lab rat gender equity.  // Hill;5/19/2014, Vol. 21 Issue 58, p17 

    The article reports that the U.S. National Institutes of Health (NIH) takes steps aimed at eliminating sex bias in pivotal biomedical studies paving the way for human clinical trials, requiring a plan for balancing male and female cells and animals in preclinical trials.

  • GET CENTRED.  // New Scientist;10/4/2003, Vol. 180 Issue 2415, p57 

    John Gallin, director of the National Institute of Health Clinical Center, couldn't have asked for more auspicious circumstances in which to celebrate the institute's 50th anniversary this year. The new building for the Clinical Center is almost complete, and the doors will open to patients next...

  • Clinical research regulations under scrutiny. Suh, Christine // R&D Magazine;Aug2002, Vol. 44 Issue 8, p38 

    Presents regulatory update of interest to the research and development community as of August 2002. Investigation of clinical research regulations due to deaths in clinical research trials; Plan of the National Institutes of Health to limit future patent rights of foreign grant and contract...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics